Krka, d. d. (WSE: KRK)
Poland flag Poland · Delayed Price · Currency is PLN
588.00
-4.00 (-0.68%)
Sep 27, 2024, 2:54 PM CET

Krka, d. d. Company Description

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

Its prescription pharmaceuticals include medicines for the treatment of cardiovascular, alimentary tract and metabolism, central nervous system, infections, oncology, and other diseases.

The company also provides non-prescription products for oral cavity and pharynx; cough and cold; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others.

In addition, it offers animal health products comprising analgesics antimicrobials, antiparasitics, disinfectants, vitamins, and minerals.

Further, the company provides health resort and tourist services. Krka, d.

d. was founded in 1954 and is headquartered in Novo Mesto, Slovenia.

Krka, d. d.
Country Slovenia
Founded 1954
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 10,284
CEO Jože Colaric

Contact Details

Address:
Šmarješka cesta 6
Novo Mesto, 8501
Slovenia
Phone 386 7 331 2111
Website krka.si

Stock Details

Ticker Symbol KRK
Exchange Warsaw Stock Exchange
Fiscal Year January - December
Reporting Currency EUR
ISIN Number SI0031102120
SIC Code 2834

Key Executives

Name Position
Jože Colaric Chief Executive Officer
Brane Kastelec Chief Financial Officer